Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 335-341

  Glatman Freedman, Aharona ^a   Mednick, Aron J ^a   Lendvai, Nikoletta ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOMANNAN; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL OUTER MEMBRANE; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUBERCULOSIS;

EID: 0033970578     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.335-341.2000     Document Type: Article

References (33)

1. Astarie-Dequeker, C., E.-N. N'Diaye, V. Le Cabec, M. G. Rittig, J. Prandi, and I. Maridonneau-Parini. 1999. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect. Immun. 67:469-177.
2. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149:541-547.
3. Besra, G. S., and D. Chatterjee. 1994. Lipids and carbohydrates of Mycobacterium tuberculosis, p. 285-306. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
4. Chan, J., X. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-1761.
5. Chang, J. C., A. Wysocki, K. Tchou-Wong, N. Moskowitz, Y. Zhang, and W. N. Rom. 1996. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metallopioteinases. Thorax 51: 306-311.
6. Chatterjee, D., K. Lowell, B. Rivoire, M. R. McNeil, and P. J. Brennan. 1992. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 267:6234-6239.
7. Coleman, R., S. Iqbal, P. P. Godfrey, and D. Billington. 1979. Membrane and bile formation: composition of several mammalian biles and their membrane-damaging properties. Biochem. J. 178:201-208.
8. Costello, A. M., A. Kumar, V. Narayan, M. S. Akbar, S. Ahmed, C. AbouZeid, G. A. W. Rook, J. Stanford, and C. Moreno. 1992. Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans. R. Soc. Trop. Med. Hyg. 86:686-692.
9. Glatman-Freedman, A., and A. Casadevall. 1998. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11:514-532.
10. Glatman-Freedman, A., J. M. Martin, P. F. Riska, B. R. Bloom, and A. Casadevall. 1996. Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J. Clin. Microbiol. 34:2795-2802.
11. Goldman, D. L., S. C. Lee, and A. Casadevall. 1995. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect. Immun. 63:3448-3453.
12. Guerin, C. 1957. The history of BCG, p. 48-53. In S. R. Rosenthal (ed.), BCG vaccination against tuberculosis. Little, Brown & Co., Boston, Mass.
13. Hansen, P. G. C, and G. D. F. Jackson. 1991. Movement of IgM antibody from blood to bile in rats. Hepatology 14:518-522.
14. Hetland, G., H. G. Wiker, K. Hogasen, B. Hamasur, S. B. Svenson, and M. Harbon. 1998. Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin. Diagn. Lab. Immunol. 5:211-218.
15. Hopf, U., H. E. Schaefer, G. Hess, and K. H. M. Z. Buschenfelde. 1981. In vivo uptake of immune complexes by parenchymal and nonparenchymal liver cells in mice. Gastroenterology 80:250-259.
16. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31-74.
17. Kraal, G., H. Ter Hart, C. Meelhuizen, G. Venneker, and E. Claassen. 1989. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: modulation of the cells with specific anti-body. Eur. J. Immunol. 19:675-680.
18. Lendvai, N., A. Casadevall, Z. Liang, D. L. Goldman, J. Mukherjee, and L. Zuckier. 1998. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. J. Infect. Dis. 177:1647-1659.
19. Ljunghusen, O., A. Johansson, and T. Skogh. 1990. Hepatic immune complex elimination studied with FITC-labelled antigen. J. Immunol. Methods 128:1-7.
20. Moreno, C., A. Mehlert, and J. Lamb. 1988. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin. Exp. Immunol. 74:206-210.
21. Mukherjee, J., A. Casadevall, and M. D. Scharff. 1993. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177:1105-1116.
22. Orme, I. M., and F. M. Collins. 1994. Mouse model of tuberculosis, p. 113-134. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
23. Prigozy, T. I., P. A. Sieling, D. Clemens, P. L. Siewart, S. M. Behar, S. A. Porcelli, M. B. Brenner, R. L. Modlin, and M. Kronnenberg. 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6:187-197.
24. Rook, G. A. W., R. Al Attiyah, and N. Foley. 1989. The role of cytokines in the immunopathology of tuberculosis and the regulation of agalactosyl IgG. Lymphokine Res. 8:323-328.
25. Russell, M. W., T. A. Brown, L. J. Claflin, K. Schroer, and J. Mestecky. 1983. Immunoglobulin A-mediated hepatobiliary transport constitutes a natural pathway for disposing of bacterial antigens. Infect. Immun. 42:1041-1048.
26. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920-2930.
27. Schlesinger, L. S., S. R. Hull, and T. M. Kaufman. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152:4070-4079.
28. Schlesinger, L. S., T. M. Kaufman, S. Iyer, S. R. Hull, and L. K. Marchiando. 1996. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol. 157:4568-4575.
29. Sousa, A. O., S. Henry, F. M. Maroja, F. K. Lee, L. Brum, M. Singh, P. H. Lagrange, and P. Aucouturier. 1998. IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clin. Exp. Immunol. 111:48-55.
30. Van Bossuyt, H., C. Desmaretz, G. B. Gaeta, and E. Wisse. 1989. The role of bile acids in the reduction in lipopolysaccharide uptake by cultured rat Kupffer cells. Virchows Arch. B 57:141-147.
31. Van Bossuyt, H., R. B. De Zanger, and E. Wisse. 1988. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J. Hepatol. 7:325-337.
32. Van Vliet, E., M. Melis, and W. Van Ewijk. 1985. Marginal zone macrophages in the mouse spleen identified by a monoclonal antibody. J. Histochem. Cytochem. 33:40-44.
33. Young, L. S. 1995. Sepsis syndrome, p. 690-705. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, Ltd., New York, N. Y.